Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-4 of 4
Keywords: Combination therapy
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Avelumab plus Axitinib for the Treatment of Patients with End-Stage Renal Disease Undergoing Dialysis: A Retrospective Case Series and Literature Review
Available to PurchaseSubject Area:
Topic Article Package: ADC (Antibody-Drug Conjugates)
, Karger e-Journal Backfile Collection 2023
, Further Areas
Yukari Bando, Junya Furukawa, Takuto Hara, Yasuyoshi Okamura, Tomoaki Terakawa, Yuzo Nakano, Masato Fujisawa
Journal:
Urologia Internationalis
Urol Int (2023) 107 (3): 321–326.
Published Online: 22 March 2023
...Yukari Bando; Junya Furukawa; Takuto Hara; Yasuyoshi Okamura; Tomoaki Terakawa; Yuzo Nakano; Masato Fujisawa Combination therapies of an immune checkpoint inhibitor and a molecular targeted agent are widely accepted as an appropriate initial systemic therapy for metastatic renal cell carcinoma (RCC...
Journal Articles
Transitional Zone Index as a Predictor of the Efficacy of α-Blocker and 5α-Reductase Inhibitor Combination Therapy in Korean Patients with Benign Prostatic Hyperplasia
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2016) 96 (4): 406–412.
Published Online: 30 January 2016
...Jae Duck Choi; Jung Hoon Kim; Seung Hyun Ahn Introduction: We investigated the value of the transitional zone index (TZI) for predicting treatment response to combination therapy involving α-blockers and 5α-reductase inhibitors for benign prostatic hyperplasia (BPH). Materials and Methods...
Journal Articles
Primary Localized Amyloidosis of the Bladder: A Case of AL (λ) Amyloid Protein and Combination Therapy Using Dimethyl Sulfoxide and Cepharanthin
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1992) 48 (2): 228–231.
Published Online: 03 February 2010
... (AP) using the KMnO 4 pre-treatment method and immunohistochemical procedures. The patient was treated successfully with intravesical dimethyl sulfoxide instillation and oral administration of high-dose cepharanthin after transurethral resection. Combination therapy with dimethyl sulfoxide...
Journal Articles
Combination Therapy of Imipramine with Oxybutynin in Children with Enuresis Nocturna
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2000) 65 (3): 135–139.
Published Online: 11 October 2000
... choice. The aim of this prospective study was the evaluation of the efficacy of combination therapy (imipramine and oxybutynin) in patients with enuresis nocturna. Patients and Methods: This prospective study was done with 77 monosymptomatic nocturnal enuretics between July 1996 and December 1998...
